Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · IEX Real-Time Price · USD
2.210
-0.050 (-2.21%)
May 3, 2024, 10:54 AM EDT - Market open
Processa Pharmaceuticals Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$6.00
Upside
+171.49%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +261.99% | Apr 25, 2024 |
| Benchmark | Benchmark | Buy Reiterates $4 | Buy | Reiterates | $4 | +81.00% | Mar 6, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 17, 2023 |
| Benchmark | Benchmark | Buy Maintains $180 → $80 | Buy | Maintains | $180 → $80 | +3,519.91% | Apr 4, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $100 → $60 | Buy | Maintains | $100 → $60 | +2,614.93% | Apr 3, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $180 → $100 | Strong Buy | Maintains | $180 → $100 | +4,424.89% | Jan 12, 2023 |
| Maxim Group | Maxim Group | Strong Buy Initiates $180 | Strong Buy | Initiates | $180 | +8,044.80% | Apr 19, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $400 | Buy | Initiates | $400 | +17,999.55% | Aug 3, 2021 |
| Oppenheimer | Oppenheimer | Buy Initiates $400 | Buy | Initiates | $400 | +17,999.55% | Aug 2, 2021 |